✦ LIBER ✦

In vitro expression of receptor activator of nuclear factor-κB ligand and osteoprotegerin in cultured equine articular cells

✍ Scribed by Byron, Christopher R.; Barger, Anne M.; Stewart, Allison A.; Pondenis, Holly C.; Fan, Timothy M.

Book ID: 111655254
Publisher: American Veterinary Medicine Association
Year: 2010
Tongue: English
Weight: 593 KB
Volume: 71
Category: Article
ISSN: 0002-9645
DOI: 10.2460/ajvr.71.6.615

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Differential expression of receptor acti

Differential expression of receptor activator of nuclear factor-κB ligand and osteoprotegerin mRNA in periodontal diseases

✍ N. Bostancı; T. İlgenli; G. Emingil; B. Afacan; B. Han; H. Töz; A. Berdeli; G. A 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 560 KB

Receptor activator of nuclear factor κB

Receptor activator of nuclear factor κB ligand and osteoprotegerin in men with thyroid cancer

✍ P. Mikosch; I. Igerc; S. Kudlacek; W. Woloszczuk; H. J. Gallowitsch; E. Kresnik; 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 169 KB

Prolactin decreases the expression ratio

Prolactin decreases the expression ratio of receptor activator of nuclear factor κB ligand/osteoprotegerin in human fetal osteoblast cells

✍ Dutmanee Seriwatanachai; Narattaphol Charoenphandhu; Tuangporn Suthiphongchai; N 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 484 KB

Role of receptor activator of nuclear fa

Role of receptor activator of nuclear factor-κB ligand and osteoprotegerin in bone cell biology

✍ Lorenz C. Hofbauer; Armin E. Heufelder 📂 Article 📅 2001 🏛 Springer 🌐 English ⚖ 119 KB

Expression of receptor activator of nucl

Expression of receptor activator of nuclear factor -κB ligand, receptor activator of nuclear factor -κB, and osteoprotegerin, following low-level laser treatment on deproteinized bovine bone graft in rats

✍ Yong-Deok Kim; Won-Wook Song; Seong-Sik Kim; Gyu-Cheon Kim; Dae-Seok Hwang; Sang 📂 Article 📅 2008 🏛 Springer-Verlag 🌐 English ⚖ 574 KB

Plasma levels of receptor activator of n

Plasma levels of receptor activator of nuclear factor-κB ligand and osteoprotegerin in patients with neuroblastoma

✍ Donatella Granchi; Alberto Garaventa; Ilaria Amato; Paolo Paolucci; Nicola Baldi 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 French ⚖ 141 KB

## Abstract Earlier reports showed that the balance between receptor activator of nuclear factor‐κB ligand (RANKL) and its decoy‐receptor osteoprotegerin (OPG) plays an important role in the pathogenesis of metastatic osteolysis induced by neuroblastoma cells. In this study, we investigated whether